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Introduction: Cranial nerve palsy is a common presentation in the neuro-ophthalmology clinic and investigations are
directed towards the cause. Metastatic breast cancer presenting as carcinomatous meningitis leading to sequential
fourth, third and sixth nerve palsy is very rare. This is the first case to be reported to the best of our knowledge.
Case presentation: A 66-year-old Caucasian woman presented with vertical double vision for the previous 3 weeks.
At 6-weeks follow up this had resolved. However, she presented with a new third and sixth cranial nerve palsy.
Neuroimaging with contrast revealed carcinomatous meningitis.
Conclusions: Metastatic cancer may manifest as cerebral metastases or carcinomatous meningitis. This is evident on
neuroimaging with contrast and may be missed on unenhanced scans.
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Carcinomatous meningitis has been reported in 5% of
breast cancers and can present with headache, cranial
nerve dysfunction, seizures and intracranial hypertension
signals [1]. Virtually all cases occur late in the natural
history of breast cancer after considerable amounts of
systemic treatment. Prognosis is poor and treatment
options limited [2,3].
It results from metastatic infiltration of the leptomen-
inges by malignant cells leading to central nervous
system dysfunction [4]. The case described here is rare
because carcinomatous meningitis manifested as cranial
nerve palsy in a woman without a known history of
breast cancer.
Case presentation
A 66-year-old Caucasian woman presented with vertical
double vision for the previous 3 weeks. Diplopia was
binocular and noticed after she banged her head against
the shower screen. She was healthy and had no symp-
toms suggestive of giant cell arteritis (GCA). A clinical
examination showed right fourth cranial nerve palsy.
Her magnetic resonance imaging (MRI) scan was* Correspondence: indiramadgula@yahoo.co.uk
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unless otherwise stated.normal. Her erythrocyte sedimentation rate (ESR) was
77mm/hour and C-reactive protein 68mg/L. She was
commenced on oral steroids while awaiting temporal
artery biopsy (TAB) to rule out GCA. TAB revealed
normal histology. As there was no clinical suspicion of
GCA, her steroids were stopped. The medics investi-
gated her further for raised inflammatory parameters
and no cause was identified.
She then sought medical attention for a breast lump
that she had noticed for the past few months. This was
clinically diagnosed as breast cancer. She subsequently
underwent right wide local excision of the mass and
axillary clearance. Histology revealed 28mm grade 3
oestrogen receptor positive, human epidermal growth
factor receptor 2 negative ductal carcinoma involving 12
of 14 axillary nodes. An oncology referral was made.
Meanwhile, she complained of a droopy right eyelid.
Orthoptic examination showed pupil-sparing third nerve
paresis and mild sixth nerve involvement. The fourth
nerve paresis had resolved. Neuroimaging to rule out
cavernous sinus pathology was requested. A MRI scan
with contrast showed meningeal thickening in frontal,
parietal and occipital lobes and no abnormality in the
cavernous sinus territory. This was consistent with car-
cinomatous meningitis (Figure 1).
By the time of her oncology appointment, she had
developed numbness in the ophthalmic division of heral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 Magnetic resonance imaging with contrast shows
enhancement of the meninges in the frontal, parietal and
occipital lobes consistent with carcinomatous meningitis.
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tases; computed tomography revealed bone spread and
abnormal mediastinal lymphadenopathy. Cerebrospinal
fluid (CSF) cytology was negative but protein was slightly
raised. Palliative hormone therapy was commenced for
metastatic breast cancer. She responded quickly with
complete resolution of diplopia, ptosis and numbness
on her right anterior scalp within 8 weeks of starting
anastrozole.
Discussion
Neoplastic meningitis is diffuse dissemination of malig-
nant cells in the meninges, CSF or both [5]. The most
common malignancies are breast and lung cancer,
melanoma and B-cell lymphoma [4,5]. It is diagnosed
clinically in 5% of patients but the incidence may be as
high as 20% in autopsy series [4]. Diagnosis is by positive
CSF cytology, radiologic evidence on neuroimaging,
clinical signs and symptoms and abnormal CSF analysis
(high white blood cell count, low glucose and elevated
protein) [4]. Patients often present with varied neuro-
logic symptoms depending on the area of central
nervous system affected [4]. There is a predilection for
sites with slow CSF flow and gravity dependent areas
allowing tumour cells to seed. Median survival in un-
treated cases is 4 to 6 weeks [4].
Brain metastases from breast cancer occur usually 42
to 60 months after primary lesion diagnosis [6]. Thiscase is rare because the patient presented with fourth
cranial nerve palsy as the first manifestation of un-
diagnosed metastatic breast malignancy. The history of
trauma preceding the onset of double vision was rela-
tively trivial and could not explain the aetiology of the
cranial mononeuropathy. Raised inflammatory parame-
ters at the initial presentation were the only clue towards
an underlying malignancy. However, the absence of any
relevant history in an apparently healthy woman did not
alert the physician towards the diagnosis at this point.
Subsequent involvement of other cranial nerves caus-
ing ophthalmoplegia pointed to a more sinister condi-
tion. By this time she had biopsy proven breast cancer.
Metastatic disease was confirmed on an MRI scan with
contrast which showed meningeal enhancement. It is
surmised that microscopic invasion of the cranial nerve
sheaths (not visible on an MRI scan) led to multiple
cranial nerve palsies. The diagnosis of metastatic
multiple cranial neuropathy so early after diagnosis of
primary cancer and as a presenting feature of breast
cancer is extremely rare and is hence reported.Conclusions
Raised inflammatory parameters in an elderly patient in
the absence of biopsy proven GCA or recent infection
should alert the ophthalmologist regarding less common,
sinister aetiologies. ESR can be raised in metastatic
breast cancer [7].
Presentation of metastatic breast cancer with fourth
and subsequent third and sixth nerve palsy is extremely
rare. This is the first such case to be reported to the best
of our knowledge.Consent
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